U.S. flag

An official website of the United States government

NM_198880.3(QRICH1):c.1655del (p.Phe552fs) AND Ververi-Brady syndrome

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Dec 22, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001800233.3

Allele description [Variation Report for NM_198880.3(QRICH1):c.1655del (p.Phe552fs)]

NM_198880.3(QRICH1):c.1655del (p.Phe552fs)

Gene:
QRICH1:glutamine rich 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
3p21.31
Genomic location:
Preferred name:
NM_198880.3(QRICH1):c.1655del (p.Phe552fs)
HGVS:
  • NC_000003.12:g.49046444del
  • NM_001320580.2:c.1655del
  • NM_001320581.2:c.1655del
  • NM_001320582.2:c.1655del
  • NM_001320583.2:c.1655del
  • NM_001320584.1:c.1655del
  • NM_001320585.1:c.1655del
  • NM_017730.4:c.1655del
  • NM_198880.3:c.1655delMANE SELECT
  • NP_001307509.1:p.Phe552fs
  • NP_001307510.1:p.Phe552fs
  • NP_001307511.1:p.Phe552fs
  • NP_001307512.1:p.Phe552fs
  • NP_001307513.1:p.Phe552fs
  • NP_001307514.1:p.Phe552fs
  • NP_060200.2:p.Phe552fs
  • NP_942581.1:p.Phe552fs
  • NC_000003.11:g.49083877del
  • NM_017730.3:c.1655del
Protein change:
F552fs
Links:
dbSNP: rs2106862871
NCBI 1000 Genomes Browser:
rs2106862871
Molecular consequence:
  • NM_001320580.2:c.1655del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001320581.2:c.1655del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001320582.2:c.1655del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001320583.2:c.1655del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001320584.1:c.1655del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001320585.1:c.1655del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_017730.4:c.1655del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_198880.3:c.1655del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Ververi-Brady syndrome
Identifiers:
MONDO: MONDO:0060707; MedGen: C4693824; OMIM: 617982

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002044394Institute of Human Genetics, University of Leipzig Medical Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Dec 21, 2021)
germlineresearch

PubMed (2)
[See all records that cite these PMIDs]

SCV005016482Equipe Genetique des Anomalies du Developpement, Université de Bourgogne
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Dec 22, 2023)
maternalclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedresearch
not providedmaternalyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder.

Kumble S, Levy AM, Punetha J, Gao H, Ah Mew N, Anyane-Yeboa K, Benke PJ, Berger SM, Bjerglund L, Campos-Xavier B, Ciliberto M, Cohen JS, Comi AM, Curry C, Damaj L, Denommé-Pichon AS, Emrick L, Faivre L, Fasano MB, Fiévet A, Finkel RS, García-Miñaúr S, et al.

Hum Mutat. 2022 Feb;43(2):266-282. doi: 10.1002/humu.24308. Epub 2021 Dec 11.

PubMed [citation]
PMID:
34859529

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Institute of Human Genetics, University of Leipzig Medical Center, SCV002044394.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Equipe Genetique des Anomalies du Developpement, Université de Bourgogne, SCV005016482.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1maternalyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 23, 2024